When Does Myopia Stop Progressing? Singapore Guide

If your child was diagnosed with myopia last year and their prescription got worse again at the most recent check-up, you have almost certainly asked the question: when does myopia stop progressing? It is one of the most common questions optometrists hear from parents across Singapore, and the answer is more nuanced than a simple age.

This guide explains what the research says about myopia stabilisation, why children in Singapore and East Asia often follow a different trajectory from Western populations, what factors influence how long progression continues, and what you can do right now to reduce the risk of your child ending up with high myopia.

What "Myopia Stabilisation" Means

Myopia progresses when the eyeball continues to elongate, pushing the focal point further in front of the retina and increasing the prescription (measured in dioptres, D). Stabilisation occurs when this axial elongation slows to negligible levels — typically defined clinically as less than −0.25 D change per year across two consecutive annual examinations.

It is important to understand that stabilisation does not mean the myopia reverses or disappears. A child who reaches −4.00 D before stabilisation will remain at −4.00 D (or thereabouts) as an adult. The goal of management is to slow the rate of progression as early as possible so that the prescription at stabilisation is as low as it can be.

The Global Evidence on When Myopia Stops Progressing

Large cross-sectional studies from Europe and North America have historically suggested that myopia stabilises somewhere between age 15 and 20 for most people. Population data show:

Roughly 50% of myopic individuals have stable prescriptions by age 15.
Around 75% are stable by age 18.
Approximately 90% are stable by age 21.
Near-complete stabilisation occurs by age 24 in most Western populations.

However, these figures come primarily from studies conducted in European-descent populations where myopia prevalence is lower and onset tends to occur later. For children in Singapore, Hong Kong, South Korea, Taiwan, and mainland China — where myopia is far more prevalent and often begins earlier in childhood — the stabilisation timeline looks meaningfully different.

Why Singapore Children Are Different

Singapore has among the highest myopia rates in the world. Studies conducted through the Singapore Eye Research Institute (SERI) and the Singapore National Eye Centre have documented myopia prevalence of around 65% in children by age 12 and up to 83% among young adults. This is not simply genetic inevitability; it reflects a combination of intense near-work demands, reduced outdoor time, and the young age at which Singaporean children typically start school and structured learning.

The key difference is age of onset. A child who becomes myopic at age 6 or 7 — which is common in Singapore — has far more growing years ahead than a child who first becomes myopic at age 13. Because the eye continues to elongate as the body grows, earlier-onset myopia has more time to accumulate additional prescription change before growth plateaus.

Research published in Ophthalmology and JAMA Ophthalmology has consistently found that:

Earlier age of onset strongly predicts higher final myopia at stabilisation.
Children who become myopic before age 8 in Singapore frequently progress by −0.8 D to −1.0 D per year during school years.
Many East Asian children continue to show measurable progression into their early to mid-20s, compared with the late-teen stabilisation common in Western cohorts.

Multiple East Asian cohort studies have found that a meaningful proportion of myopic young adults in the region are still showing measurable progression at age 22 or beyond — a pattern much less common in Western populations. This prolonged progression is particularly associated with individuals who had early-onset or high myopia.

Does Myopia Ever Stop on Its Own?

Yes — for the vast majority of people, myopia does eventually stabilise without intervention. The progression is not lifelong. However, "stopping on its own" and "stopping at a safe prescription level" are two different things.

High myopia is defined as −6.00 D or more. At this level, the risk of serious complications rises significantly:

Retinal detachment: The lifetime risk is approximately 1 in 50 for high myopes versus 1 in 10,000 for the general population.
Myopic macular degeneration: Structural changes to the central retina that can cause permanent vision loss.
Glaucoma: High myopia doubles the risk of developing glaucoma.
Cataracts: Early-onset nuclear cataracts are more common in high myopes.

This is why the question is not merely academic. If your child's myopia is progressing at −1.0 D per year and started at age 7 with a −1.50 D prescription, a simple linear trajectory puts them at −6.50 D by age 14 — well into high-myopia territory — even if progression stops completely at that point. Early intervention changes that trajectory.

For a personalised estimate of where your child's myopia could end up without treatment — and how different interventions might change the outcome — use the CarrotByte Myopia Progression Calculator. It uses validated prediction models to project progression to age 17 based on your child's current age and prescription.

Factors That Influence When Myopia Stabilises

While no one can predict with certainty when an individual child's myopia will stop progressing, several factors reliably influence the timeline.

1. Age at Onset

The single strongest predictor. Children who become myopic at age 6 will almost certainly progress for longer and reach higher prescriptions at stabilisation than those who first become myopic at age 14. This is why optometrists in Singapore recommend intervention as early as possible after myopia is detected, not waiting to see how bad it gets.

2. Current Rate of Progression

A child progressing at −1.0 D or more per year is statistically likely to continue progressing at an elevated rate for several more years. A child progressing at −0.25 D per year is often closer to natural stabilisation. Annual eye checks that track axial length — the physical length of the eye measured in millimetres, rather than just the spectacle prescription — give the most sensitive early warning of accelerating progression.

3. Parental Myopia

Both parents being myopic roughly doubles the risk of a child having myopia and is also associated with faster progression. This is partly genetic (genes influencing eye growth) and partly environmental (myopic parents may share lifestyle patterns with their children, such as high amounts of near work).

4. Amount of Outdoor Time

Sunlight exposure — specifically high-intensity light triggering retinal dopamine release — is the most robust environmental factor shown to slow myopia onset and, to a lesser degree, progression. The two-hour daily outdoor recommendation from the Singapore Health Promotion Board and the World Health Organization is grounded in this evidence. Children who consistently achieve two or more hours of outdoor time per day tend to show slower progression rates than peers who spend most of the day indoors.

5. Treatment Status

Children receiving evidence-based myopia control treatment — atropine eye drops, orthokeratology, DIMS or MiYOSMART spectacle lenses, or multifocal soft contact lenses — typically progress at a meaningfully slower rate. While none of these treatments fully arrests progression, they reduce the total accumulated prescription by the time stabilisation occurs, which is clinically significant for long-term eye health.

What About Adult-Onset and Late Progression?

Some individuals who were not myopic in childhood develop myopia in their late teens or early adult years, often triggered by intensive near-work environments such as university study or office work. This adult-onset myopia tends to be milder (usually below −3.00 D) and stabilises relatively quickly — often within two to three years of onset.

More concerning is myopia that continues to progress slowly into adulthood in people who were already myopic as children. A proportion of individuals — particularly those with early-onset or high myopia — continue to show measurable axial elongation well into their 30s. Prolonged screen work and reduced outdoor time in adult life may play a role, though the evidence here is less definitive than for childhood progression.

If an adult myope notices their glasses prescription worsening year on year, this warrants discussion with an optometrist to rule out secondary causes such as early nuclear cataract (which can shift refraction towards myopia) and to consider whether any modifiable lifestyle factors are contributing.

Practical Guidance for Singapore Parents

Given the evidence, here is what optometrists in Singapore generally recommend:

Book annual check-ups — at minimum. For a child with myopia progressing faster than −0.50 D per year, six-monthly reviews are more appropriate. Tracking axial length at every visit gives a more sensitive picture of progression than refraction alone.

Start myopia control early. The best time to begin intervention is when progression is first confirmed — not after the prescription has doubled. Atropine 0.025% or 0.05% remains a first-line recommendation in Singapore for children with active progression. Orthokeratology, DIMS lenses, and MiYOSMART lenses are all established alternatives or add-ons.

Protect outdoor time. Two hours per day outdoors remains the most accessible, cost-free intervention with strong supporting evidence. Structured outdoor activities, walking to school, and screen-free play all count.

Do not assume progression will stop at a predictable age. Given how early Singaporean children typically become myopic, expecting stabilisation by 15 or 16 — as might be reasonable in a European child — is often unrealistic. Planning for active management through the late teens is prudent.

Track axial length, not just prescription. A prescription that appears stable can mask continued axial elongation, particularly when accompanied by changes in lens power during adolescence. Axial length measurement with a biometer (such as the Zeiss IOLMaster or similar instruments) provides the most direct measure of eye growth.

When to Have a Deeper Conversation with Your Optometrist

Consider requesting a detailed myopia management review if:

Your child's prescription has changed by more than −0.50 D in the past year.
Your child's myopia developed before age 8.
Both parents are myopic (especially with prescriptions above −3.00 D).
Your child is already approaching −4.00 D or higher.
You have not had axial length measured alongside the standard refraction check.

Optometrists who specialise in myopia management will have the instruments and the clinical protocols to assess your child's individual risk and recommend the most appropriate intervention combination.

Use the CarrotByte Eye Care Directory to find myopia management specialists near you in Singapore and across Southeast Asia.

Key Takeaways

Myopia typically stabilises between ages 18 and 24, but this timeline is based largely on Western data.
In Singapore and East Asia, earlier onset and faster progression mean many children continue progressing into their early-to-mid 20s.
The age at onset is the strongest predictor of both duration of progression and final prescription at stabilisation.
High myopia (−6.00 D or more) significantly increases the lifetime risk of serious, sight-threatening complications.
Evidence-based treatments — atropine, orthokeratology, and myopia control spectacles — slow progression and reduce the final prescription, which matters enormously for long-term eye health.
Annual eye checks with axial length measurement are the best way to track whether myopia has stabilised.

Understanding when myopia stops progressing is only one part of the picture. Knowing what you can do before it stops — while there is still time to influence the outcome — is what makes the real difference. If you want to see how your child's trajectory compares to published data and how different treatments might change the endpoint, the CarrotByte Myopia Progression Calculator is a free, evidence-based tool built for exactly this purpose.